# Efficacy and Safety Study of DERMAGEN® vs Conventional Treatment to Treat Diabetic Neuropathic Foot Ulcer

> **NCT00521937** · PHASE3 · UNKNOWN · sponsor: **Laboratoires Genévrier** · enrollment: 388 (estimated)

## Conditions studied

- Diabetes
- Foot Ulcer

## Interventions

- **OTHER:** Dermagen®

## Key facts

- **NCT ID:** NCT00521937
- **Lead sponsor:** Laboratoires Genévrier
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2010-06
- **Final completion:** 2010-12
- **Target enrollment:** 388 (ESTIMATED)
- **Last updated:** 2010-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00521937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00521937, "Efficacy and Safety Study of DERMAGEN® vs Conventional Treatment to Treat Diabetic Neuropathic Foot Ulcer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00521937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*